Asymmetry Capital Management’s DexCom DXCM Stock Holding History

Asymmetry Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-59,080	Closed	-$2.2M	–	36
2019 Q3	$2.2M	Buy	+59,080	New	+$2.3M	4.72%	9

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Asymmetry Capital Management's DXCM Position: Q4 2019 in Review

Asymmetry Capital Management sold out of DexCom (DXCM) in Q4 2019, closing a stake of 59,080 shares — an estimated $2.2M sold.

Asymmetry Capital Management first reported a position in DXCM in Q3 2019 and held it in 1 quarter. The position peaked at $2.2M in Q3 2019. 509 funds tracked by Wall St. Rank hold DXCM as of Q4 2019.

Asymmetry Capital Management reported no remaining DexCom position as of Q4 2019 after selling out during the quarter.
Asymmetry Capital Management sold 59,080 DexCom shares in Q4 2019, an estimated $2.2M.
Asymmetry Capital Management first reported a position in DexCom in Q3 2019 and held it in 1 quarter.
Asymmetry Capital Management's DexCom position peaked at $2.2M in Q3 2019.
509 funds tracked by Wall St. Rank held DexCom as of Q4 2019.

Based on Asymmetry Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.